HANGZHOU FANSI TRADING CO., LTD – Trademark Portfolio
Entity Type: 99
HANGZHOU FANSI TRADING CO., LTD has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 100% registration rate. The portfolio includes marks such as LEKEBOBOR and PRELIFE MEMORY. Filings span 3 Nice Classification classes, with the highest activity in Class 14 (Jewelry) and Class 18 (Leather Goods). This trademark owner is based in HANGZHOU, ZHEJIANG.
312, BLK.C, BLDG.3, NO. 228 BINKANG RD.,
HANGZHOU, ZHEJIANG 310000 , CN
Showing of trademarks Trademarks
Trademark Classifications
HANGZHOU FANSI TRADING CO., LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Precious metals and their alloys; jewellery, precious stones; horological instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does HANGZHOU FANSI TRADING CO., LTD have?
HANGZHOU FANSI TRADING CO., LTD has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does HANGZHOU FANSI TRADING CO., LTD file in?
HANGZHOU FANSI TRADING CO., LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 18 (Leather Goods), Class 34 (Smokers Articles). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.
What are HANGZHOU FANSI TRADING CO., LTD's most well-known trademarks?
HANGZHOU FANSI TRADING CO., LTD's registered trademark portfolio includes well-known marks such as LEKEBOBOR and PRELIFE MEMORY. These are among 3 currently registered trademarks in the portfolio.
What is HANGZHOU FANSI TRADING CO., LTD's trademark registration success rate?
HANGZHOU FANSI TRADING CO., LTD has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.